IP Library Granted Patent US 7,285,651
Granted Patent B2
US 7,285,651 · App. 10/922,324 · Granted Oct 23, 2007

Process for the scaleable purification of plasmid DNA

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,285,651
App. No.
10/922,324
Granted
Oct 23, 2007
Kind
B2
Abstract

The present invention relates to a nonchromatographic-based process for the isolation of clinical grade plasmid DNA from bacterial cells. The exemplified methods described herein outline a scaleable, economically favorable protocol for the purification of clinical grade plasmid DNA from E. coli which includes CTAB-based precipitation of DNA in combination with adsorption of impurities to calcium silicate.

Claims (13)

1. A method of purifying supercoiled plasmid DNA from a cell lysate of a large scale microbial fermentation which comprises adding hydrated, crystallized calcium silicate to the cell lysate to adsorb residual impurities away from the supercoiled plasmid DNA.

2. A method of claim 1 wherein the cell lysate is clarified prior to addition of the hydrated, crystallized calcium silicate.

3. A method of claim 2 wherein the cell lysate is clarified by addition of diatomaceous earth.

4. A method of claim 3 wherein the supercoiled plasmid DNA is further concentrated by a process selected from the group consisting of alcohol precipitation and ultrafiltration.

5. A method of claim 4 wherein the supercoiled plasmid DNA is concentrated by ethanol precipitation.

6. A method of claim 1 wherein the supercoiled plasmid DNA is further concentrated by a process selected from the group consisting of alcohol precipitation and ultrafiltration.

7. A method of claim 6 wherein the supercoiled plasmid DNA is concentrated by ethanol precipitation.

8. A method of claim 1 wherein the hydrated, crystallized calcium silicate is added in a stepwise manner.

9. A method of claim 8 wherein the cell lysate is clarified by addition of diatomaceous earth.

10. A method of claim 9 wherein the supercoiled plasmid DNA is further concentrated by a process selected from the group consisting of alcohol precipitation and ultrafiltration.

11. A method of claim 10 wherein the supercoiled plasmid DNA is concentrated by ethanol precipitation.

12. A method of claim 1 wherein the hydrated, crystallized calcium silicate has a surface area of greater than about 75 m 2 /g.

13. A method of claim 12 wherein the hydrated, crystallized calcium silicate is in a composition comprising 25-35% calcium oxide by weight and 45-55% silicon dioxide by weight.

Assignments (3)
CHANGE OF NAME Recorded Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
MERGER Recorded Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
CHANGE OF NAME Recorded Jan 29, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023861/0910 →